Literature DB >> 17887745

Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.

Yan-Zhen He1, Yuan-Xiang Li, Xiao-Lei Zhu, Zhen Xi, Congwei Niu, Jian Wan, Li Zhang, Guang-Fu Yang.   

Abstract

Pyrimidinylthiobenzoates constitute an important kind of herbicides targeting acetohydroxyacid synthase (AHAS, EC 2.2.1.6), which catalyze the first common step in branched-chain amino acid biosynthesis. Due to the symmetry of 4,6-dimethoxypyrimidyl, there are two kinds of conformation of pyrimidinylthiobenzoates: one's phenyl is left-extending (named conformation-L); the other's phenyl is right-extending (named conformation-R). On the basis of the assumption that 3D quantitative structure-activity relationship (QSAR) models derived from the bioactive conformation should give the best result, a strategy of density-functional-theory-based 3D-QSAR was proposed to identify the bioactive conformation of pyrimidinylthiobenzoates by integrating the techniques of molecular docking, comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA), and density functional theory calculation. The combination of three criteria of q2, r2, and r2pred obtained from CoMFA and CoMSIA analyses clearly indicated that conformation-R rather than conformation-L might be the bioactive conformation for pyrimidinylthiobenzoates. A further comparison between the two binding modes indicated that pyrimidinylthiobenzoates and sulfonylureas have very similar binding sites, such as Trp586, Arg380, and Pro192. However, Lys251 formed H bonds with sulfonylureas rather than pyrimidinylthiobenzoates. In addition, the orientation of phenyl groups of the two classes of compounds in the binding pocket were revealed to be opposite, which explained why the mutation of Pro192 displayed different sensitivity to sulfonylureas and pyrimidinylthiobenzoates. On the basis of the understanding of interactions between pyrimidinyl-thiobenzoates and AHAS, we designed and synthesized six 8-(4,6-dimethoxypyrimidin-2-yloxy)-4-methylphthalazin-1-one derivatives according to the 3D-QSAR models. The excellent correlation between the tested Ki values against wild-type A. thaliana acetohydroxyacid synthase and the predicted IC50 values demonstrated the high reliability of the established 3D-QSAR models. To our knowledge, this is the first report highlighting the binding mode of herbicidal pyrimidinylthiobenzoates, which consisted of the reported results of herbicide resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17887745     DOI: 10.1021/ci7002297

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  6 in total

1.  Methyl 2,6-bis-[(5-bromo-4,6-dimeth-oxy-pyrimidin-2-yl)-oxy]benzoate.

Authors:  Hoong-Kun Fun; Jia Hao Goh; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-30

2.  Methyl 2,6-bis-[(5-chloro-4,6-dimeth-oxy-pyrimidin-2-yl)-oxy]benzoate.

Authors:  Hoong-Kun Fun; Jia Hao Goh; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-30

3.  4,6-Dimeth-oxy-2-(methyl-sulfon-yl)pyrimidine.

Authors:  Hoong-Kun Fun; Chin Sing Yeap; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-03

4.  3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking.

Authors:  Yinghua Jin; Ping Qi; Zhiwei Wang; Qirong Shen; Jian Wang; Weige Zhang; Hongrui Song
Journal:  Molecules       Date:  2011-08-08       Impact factor: 4.411

5.  Synthesis and biological activity of 4-(4,6-disubstituted-pyrimidin-2-yloxy)phenoxy acetates.

Authors:  Lin Jiang; Hao Wang; Maorong Wang; Xinhuan Teng
Journal:  Molecules       Date:  2010-02-23       Impact factor: 4.411

6.  Improvement of the Prediction Power of the CoMFA and CoMSIA Models on Histamine H3 Antagonists by Different Variable Selection Methods.

Authors:  Jahan B Ghasemi; Hossein Tavakoli
Journal:  Sci Pharm       Date:  2012-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.